Publication | Closed Access

Treatment with a histone deacetylase inhibitor, valproic acid, is associated with increased platelet activation in a large animal model of traumatic brain injury and hemorrhagic shock

ThrombopoiesisThrombosisTraumatic Brain InjuryValproic AcidHistone Deacetylase InhibitorBlood PlateletMedicineHematologyHemostasisNeuropharmacologyBrain InjuryNeurologyConcussionCerebral Blood FlowPlatelet AntagonistPharmacologyReperfusion InjuryHealth Sciences